The company released the email correspondences. It made AF look like a high school drop out. Just FYI. AF could be the most uneducated blogger in the bio arena. IMO. Good luck
Do you then recall how ex-CEO George Evans ever settled his dispute with Leo regarding being properly compensated ? Although I remember the dispute, can't recall the settlement.
Sounds like at the time George Evans wasn't very pleased with Leo and it prompted him to file this email with U.S. regulators;
I was here back in the day when George Evans was replaced by Leo and back then Leo spoke about the little biotech that BP was so interested in and by now it is getting tiresome to hear this over and over. I still think it will, despite management, hit the mother lode. Management has made a bad impression with too large a percentage of investors and each PR gets them further in trouble.
I don't understand the mentality that if only management were out of the way the science could prevail. B was purchased off the trash heap. Nobody wanted it. A flailing OTC Pink Sheet stock picked it up and sent PR's to Obama to pump the stock up and secure financing to keep the lights on for a few years.
K did have a chance at one point. The odds of it having an impact have diminished to near zero.
Luckily for Menon, he probably found a way to capitalize on K through Aruda. Pretty genius way to do it and the shareholders never asked for a detailed reason that the Aruda settlement came out of nowhere.